NCT01975272View on ClinicalTrials.gov

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

PHASE4TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 2, 2015

Primary Completion Date

May 17, 2018

Study Completion Date

June 21, 2018

Conditions
Postoperative Anaemia
Interventions
DRUG

Ferinject

DRUG

Ferrous fumarate

DRUG

Placebo for ferrous fumarate

DRUG

Placebo for ferinject

Trial Locations (2)

6202 AZ

Maastricht University Medical Centre, Maastricht

6162 BG

Orbis Medical Centre, Sittard

Sponsors

Collaborators (1)

Vifor Pharma
All Listed Sponsors
collaborator

Vifor Pharma

INDUSTRY

lead

Maastricht University Medical Center

OTHER

NCT01975272 - The Use of Iron Therapy for Patients With Anemia After Caesarean Section | Biotech Hunter | Biotech Hunter